Primera página del artículo de sobre bronquiectasias. THEODORE WILLIAMS, C. la fisiopatología de las bronquiectasias. El conocimiento acerca de. RESUMO: As bronquiectasias, outrora frequentes, têm vindo a tomarse numa situação patológia comparativamente rara. No entanto, a sua importância clínica . Las bronquiectasias no asociadas a fibrosis quística son una enfermedad compleja que ha despertado cada vez más interés científico debido a su creciente.
| Author: | Yomi Malajin |
| Country: | Gambia |
| Language: | English (Spanish) |
| Genre: | Health and Food |
| Published (Last): | 10 February 2012 |
| Pages: | 126 |
| PDF File Size: | 16.75 Mb |
| ePub File Size: | 4.73 Mb |
| ISBN: | 977-9-16057-210-1 |
| Downloads: | 42788 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Sagal |
Chang AB, Bilton D. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. British Thoracic Society guideline for non-CF bronchiectasis.
Bronquiectasias
Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis. Ann Am Thorac Soc.

Inhaled hyperosmolar agents for bronchiectasis. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Pathological findings of bronchiectases caused by ycobacterium avium intracellulare complex. Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with noncystic fibrosis bronchiectasis.
Exacerbations in cystic fibrosis: Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms.
Chest physiotherapy techniques in bronchiectasis. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Entendendo a classificação, a fisiopatologia e o diagnóstico radiológico das bronquiectasias
State of the art review: Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. An international derivation and validation study. Systemic comorbidities in bronchiectasis. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: Bronchiectasis-associated hospitalizations in Germany, Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.
Assessing response to treatment of exacerbations of bronchiectasis in adults.
Monografías de Archivos de Bronconeumología
A prospective cohort analysis. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Cochrane Database Syst Rev.
Recent Advances and Continuing Challenges. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: Controlled trial of ceftazidime vs.
Bronquiectasias | Blausen Medical
Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis. British Thoracic Society Research Committee. Bilateral bronchiectasis and bronchiolitis at thin-section CT: A novel microbiota stratification system predicts future exacerbations in bronchiectasis.

